| Breakdown | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 929.24M | 628.24M | 545.19M | 654.85M | 591.52M |
| Gross Profit | 58.99M | 61.09M | 53.56M | 82.80M | 23.66M |
| EBITDA | -48.97M | 73.86M | 23.18M | 78.98M | 8.02M |
| Net Income | -80.71M | 2.86M | -20.80M | 5.50M | -55.00M |
Balance Sheet | |||||
| Total Assets | 1.21B | 1.10B | 1.03B | 812.60M | 1.08B |
| Cash, Cash Equivalents and Short-Term Investments | 115.17M | 37.32M | 134.54M | 117.46M | 66.69M |
| Total Debt | 254.30M | 204.50M | 218.87M | 80.75M | 150.95M |
| Total Liabilities | 833.93M | 637.59M | 626.99M | 573.16M | 947.70M |
| Stockholders Equity | 319.77M | 399.25M | 359.38M | 191.04M | 100.48M |
Cash Flow | |||||
| Free Cash Flow | 20.16M | -53.94M | -252.41M | 86.19M | 12.63M |
| Operating Cash Flow | 36.14M | -33.75M | -14.14M | 102.70M | 23.24M |
| Investing Cash Flow | -60.86M | -49.57M | -263.89M | -9.04M | 12.91M |
| Financing Cash Flow | 102.69M | 5.03M | 307.58M | -43.76M | 483.00K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | HK$1.08B | 4.47 | 13.68% | 9.09% | 26.57% | -2.39% | |
67 Neutral | HK$118.64M | 48.82 | 4.27% | 25.00% | 126.51% | ― | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | HK$1.42B | -5,978.10 | -0.11% | ― | -2.02% | -101.97% | |
56 Neutral | HK$798.98M | 71.49 | 3.56% | ― | 14.96% | 512.50% | |
46 Neutral | HK$280.35M | -3.33 | -6.00% | 7.35% | 24.69% | -257.79% | |
43 Neutral | HK$171.98M | -1.47 | -25.76% | ― | 38.15% | -1533.02% |